 Connection
Jorge Saucedo to Hemorrhage
This is a "connection" page, showing publications Jorge Saucedo has written about Hemorrhage.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.222 |
|
|
|
-
Hanna EB, Rao SV, Manoukian SV, Saucedo JF. The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomes. JACC Cardiovasc Interv. 2010 Dec; 3(12):1209-19.
Score: 0.305
-
Grodecki K, Huczek Z, Scislo P, Kowara M, Raposeiras-Roub?n S, D'Ascenzo F, Abu-Assi E, Henriques JPS, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song XT, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Opolski G, Filipiak KJ. Gender-related differences in post-discharge bleeding among patients with acute coronary syndrome on dual antiplatelet therapy: A BleeMACS sub-study. Thromb Res. 2018 08; 168:156-163.
Score: 0.129
-
Raposeiras-Roub?n S, Fax?n J, ??iguez-Romo A, Henriques JPS, D'Ascenzo F, Saucedo J, Szummer K, Jernberg T, James SK, Juanatey JRG, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Caneiro-Queija B, Cobas-Paz R, Acu?a JMG, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Rivera-Asenjo D, Abu-Assi E. Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score. Int J Cardiol. 2018 03 01; 254:10-15.
Score: 0.125
-
D'Ascenzo F, Abu-Assi E, Raposeiras-Roub?n S, Simao Henriques JP, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia LC, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Kowara M, Filipiak KJ, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S. BleeMACS: rationale and design of the study. J Cardiovasc Med (Hagerstown). 2016 Oct; 17(10):744-9.
Score: 0.114
-
Wayangankar SA, Roe MT, Chen AY, Gupta RS, Giugliano RP, Newby LK, de Lemos JA, Alexander KP, Sanborn TA, Saucedo JF. Trends in use of anti-thrombotic agents and outcomes in patients with non-ST-segment elevation myocardial infarction (NSTEMI) managed with an invasive strategy. Indian Heart J. 2016 Jul-Aug; 68(4):464-72.
Score: 0.109
-
Karrowni W, Wang TY, Chen AY, Thomas L, Saucedo JF, El Accaoui RN. Chronic vitamin K antagonist therapy and bleeding risk in ST elevation myocardial infarction patients. Heart. 2015 Feb; 101(4):264-70.
Score: 0.100
-
Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011 Sep; 4(9):1002-8.
Score: 0.080
-
Saucedo JF. Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention. J Thromb Thrombolysis. 2010 Aug; 30(2):200-9.
Score: 0.074
-
Abu-Fadel MS, Sparling JM, Zacharias SJ, Aston CE, Saucedo JF, Schechter E, Hennebry TA. Fluoroscopy vs. traditional guided femoral arterial access and the use of closure devices: a randomized controlled trial. Catheter Cardiovasc Interv. 2009 Oct 01; 74(4):533-9.
Score: 0.070
-
Iannaccone M, D Ascenzo F, De Filippo O, Gagliardi M, Southern DA, Raposeiras-Roub?n S, Abu-Assi E, Henriques JPS, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Moretti C, Gaita F, Kalpak O, Kedev S. Optimal Medical Therapy in Patients with Malignancy Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: a BleeMACS Sub-Study. Am J Cardiovasc Drugs. 2017 Feb; 17(1):61-71.
Score: 0.029
-
Giordana F, Montefusco A, D'Ascenzo F, Moretti C, Scarano S, Abu-Assi E, Raposeiras-Roub?n S, Henriques JP, Saucedo J, Gonz?lez-Juanatey JR, Wilton SB, Kikkert WJ, Nu?ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, Garc?a-Acu?a JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M?llmann H, Shiomi H, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Gaita F. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe. Int J Cardiol. 2016 Oct 01; 220:488-95.
Score: 0.028
-
Hess CN, Peterson ED, Peng SA, de Lemos JA, Fosbol EL, Thomas L, Bhatt DL, Saucedo JF, Wang TY. Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation. J Am Coll Cardiol. 2015 Aug 11; 66(6):616-27.
Score: 0.026
-
Diercks DB, Kontos MC, Hollander JE, Mumma BE, Holmes DN, Wiviott S, Saucedo JF, de Lemos JA. ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR. Am J Emerg Med. 2013 Jul; 31(7):1005-11.
Score: 0.023
-
Zhang Z, Mahoney EM, Gershony G, Ellis S, Saucedo JF, Talley JD, Feldman T, Weintraub WS. Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial. Am Heart J. 2001 Dec; 142(6):982-8.
Score: 0.010
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|